Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Panbela Therapeutics Inc (NQ: PBLA ) N/A UNCHANGED Last Price Updated: 4:00 PM EST, Mar 6, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open - Bid (Size) 1.020 (5) Ask (Size) 1.040 (1) Prev. Close 1.110 Today's Range N/A - N/A 52wk Range 1.060 - 38.00 Shares Outstanding 5,127,686 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News PBLA Stock Earnings: Panbela Therapeutics Misses EPS for Q1 2024 May 15, 2024 PBLA stock results show that Panbela Therapeutics missed analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace Panbela Announces Issuance of New Patent in the US and Canada; Patent is for Claims of a Fixed Dose Combination of Eflornithine and Sulindac May 06, 2024 Developed in collaboration with Sanofi. From Panbela Therapeutics, Inc. Via GlobeNewswire Performance More News Read More Panbela to Host First Quarter 2024 Earnings Conference Call on May 15, 2024 May 01, 2024 From Panbela Therapeutics, Inc. Via GlobeNewswire Recap: Panbela Therapeutics Q4 Earnings March 26, 2024 Via Benzinga Earnings Preview: Panbela Therapeutics March 25, 2024 Via Benzinga Acceptance of Eflornithine (DFMO) Abstract for Oral Presentation at Digestive Disease Week April 30, 2024 From Panbela Therapeutics, Inc. Via GlobeNewswire Panbela Therapeutics Announces Interim Data Analysis for ASPIRE Trial Pushed to Q1 2025 April 22, 2024 From Panbela Therapeutics, Inc. Via GlobeNewswire Panbela Announces Poster Presentation at American Association for Cancer Research: April 18, 2024 From Panbela Therapeutics, Inc. Via GlobeNewswire Panbela Announces Transfer to OTCQB Market April 16, 2024 From Panbela Therapeutics, Inc. Via GlobeNewswire PBLA Stock Earnings: Panbela Therapeutics Misses EPS for Q4 2023 March 26, 2024 Via InvestorPlace Panbela to Host Fourth Quarter and Year End 2023 Earnings Conference Call on March 26, 2024 March 12, 2024 From Panbela Therapeutics, Inc. Via GlobeNewswire Top 4 Health Care Stocks That Are Preparing To Pump This Month February 23, 2024 Via Benzinga Panbela Regains Compliance with Nasdaq Listing Standards for Bid Price and Publicly Held Shares Requirements February 15, 2024 From Panbela Therapeutics, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Wednesday's After-Market Session February 14, 2024 Via Benzinga BioMedNewsBreaks – Panbela Therapeutics Inc. (NASDAQ: PBLA) Secures ~$9M in Public Offering February 01, 2024 Via Investor Brand Network Panbela Announces Closing of Approximately $9.0 Million Public Offering February 01, 2024 From Panbela Therapeutics, Inc. Via GlobeNewswire What's Going On With Panbela Therapeutics Stock Today? January 30, 2024 Via Benzinga Acceptance of Ivospemin (SBP-101) Abstract for Poster Presentation at American Association for Cancer Research (AACR) January 30, 2024 From Panbela Therapeutics, Inc. Via GlobeNewswire Crude Oil Down Over 1%; Science 37 Holdings Shares Spike Higher January 29, 2024 Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities Why Panbela Therapeutics Shares Are Trading Lower By 65%? Here Are Other Stocks Moving In Monday's Mid-Day Session January 29, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session January 29, 2024 Via Benzinga Dow Edges Lower; Cardlytics Shares Jump January 29, 2024 Via Benzinga Topics Stocks Exposures US Equities US Stocks Edge Higher; Amazon And iRobot Agree To Terminate Acquisition Deal January 29, 2024 Via Benzinga Topics Stocks Exposures US Equities Why Is Aclarion (ACON) Stock Down 16% Today? January 29, 2024 Via InvestorPlace Why Is Panbela Therapeutics (PBLA) Stock Down 63% Today? January 29, 2024 Via InvestorPlace Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
